Type 2 diabetes and risk of rupture of saccular intracranial aneurysm in eastern Finland

Diabetes Care

Volumn 36, Issue 7, 2013, Pages 2020-2026

  Lindgren, Antti E ^a   Kurki, Mitja I ^a   Riihinen, Annamaija ^a   Koivisto, Timo ^a   Ronkainen, Antti ^a   Rinne, Jaakko ^a   Hernesniemi, Juha ^b   Eriksson, Johan G ^b,c,d,e,f   Jääskeläinen, Juha E ^a   Von Und Zu Fraunberg, Mikael ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e VAASA CENTRAL HOSPITAL   (Finland)

^f FOLKHÄLSAN RESEARCH CENTER   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; GLUCOSE;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FINLAND; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; INTRACRANIAL ANEURYSM; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PUNCTURE; RISK FACTOR; SACCULAR INTRACRANIAL ANEURYSM; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FINLAND; HUMANS; INCIDENCE; INTRACRANIAL ANEURYSM; MIDDLE AGED; RISK FACTORS;

EID: 84886071321     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1048     Document Type: Article

References (39)

1. van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet 2007; 369:306-318
2. Ronkainen A, Miettinen H, Karkola K, et al. Risk of harboring an unruptured intracranial aneurysm. Stroke 1998;29: 359-362
3. Feigin VL, RinkelGJ, Lawes CM, et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 2005;36:2773-2780
4. Feigin VL, LawesCM, Bennett DA, Barker- Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009;8:355-369
5. de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry 2007;78:1365-1372
6. Helgadottir A, Thorleifsson G,Magnusson KP, et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 2008; 40:217-224
7. Bilguvar K, Yasuno K, Niemelä M, et al. Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat Genet 2008;40:1472-1477
8. Yasuno K, Bilguvar K, Bijlenga P, et al. Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat Genet 2010;42:420-425
9. Ronkainen A, Hernesniemi J, Puranen M, et al. Familial intracranial aneurysms. Lancet 1997;349:380-384
10. Ruigrok YM, Rinkel GJ, Wijmenga C. Familial intracranial aneurysms. Stroke 2004; 35:e59-60
11. Huttunen T, von und zu Fraunberg M, Frösen J, et al. Saccular intracranial aneurysm disease: distribution of site, size, and age suggests different etiologies for aneurysm formation and rupture in 316 familial and 1454 sporadic eastern Finnish patients. Neurosurgery 2010;66:631- 638; discussion 638
12. Huttunen T, von und Zu Fraunberg M, Koivisto T, et al. Long-term excess mortality of 244 familial and 1502 sporadic one-year survivors of aneurysmal subarachnoid hemorrhage compared with a matched Eastern Finnish catchment population. Neurosurgery 2011;68:20-27
13. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011;34(Suppl. 1):S62-S69
14. Lyssenko V, Jonsson A, Almgren P, et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 2008;359:2220-2232
15. Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003;26: 725-731
16. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 2011;378:169-181
17. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a populationbased study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004;164:1422-1426
18. O'Donnell MJ, Xavier D, Liu L, et al.; INTERSTROKE investigators. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010;376:112-123
19. Sarwar N, Gao P, Seshasai SR, et al.; Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-αnalysis of 102 prospective studies. Lancet 2010;375: 2215-2222
20. Ruiz-Sandoval JL, Cantú C, Chiquete E, et al.; RENAMEVASC Investigators. Aneurysmal subarachnoid hemorrhage in a Mexican multicenter registry of cerebrovascular disease: the RENAMEVASC study. J Stroke Cerebrovasc Dis 2009;18:48-55
21. Inagawa T. Risk factors for the formation and rupture of intracranial saccular aneurysms in Shimane, Japan. World Neurosurg. 2010;73:155-164
22. Koshy L, Easwer HV, Premkumar S, et al. Risk factors for aneurysmal subarachnoid hemorrhage in an Indian population. Cerebrovasc Dis 2010;29:268-274
23. Cui R, Iso H, Yamagishi K, et al. Diabetes mellitus and risk of stroke and its subtypes among Japanese: the Japan public health center study. Stroke 2011;42:2611-2614
24. Ohkuma H, Tabata H, Suzuki S, Islam MS. Risk factors for aneurysmal subarachnoid hemorrhage in Aomori, Japan. Stroke 2003;34:96-100
25. Kissela BM, Sauerbeck L, Woo D, et al. Subarachnoid hemorrhage: a preventable disease with a heritable component. Stroke 2002;33:1321-1326
26. Kubota M, Yamaura A, Ono J. Prevalence of risk factors for aneurysmal subarachnoid haemorrhage: results of a Japanese multicentre case control study for stroke. Br J Neurosurg 2001;15:474-478
27. Qureshi AI, Suri MF, Yahia AM, et al. Risk factors for subarachnoid hemorrhage. Neurosurgery 2001;49:607-612; discussion 612-613
28. Shiue I, Arima H, Hankey GJ, Anderson CS; ACROSS Group. Modifiable lifestyle behaviours account for most cases of subarachnoid haemorrhage: a populationbased case-control study in Australasia. J Neurol Sci 2012;313:92-94
29. Okamoto K, Horisawa R, Ohno Y. The relationships of gender, cigarette smoking, and hypertension with the risk of aneurysmal subarachnoid hemorrhage: a case-control study in Nagoya, Japan. Ann Epidemiol 2005;15:744-748
30. Voight BF, Scott LJ, Steinthorsdottir V, et al.; MAGIC investigators; GIANT Consortium. Twelve type 2 diabetes susceptibility loci identified through largescale association analysis. Nat Genet 2010; 42:579-589
31. Scott LJ,Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007;316: 1341-1345
32. Lindgren A, Huttunen T, Saavalainen T, et al. Increased incidence of aneurysmal subarachnoid hemorrhage on Sundays and Mondays in 1,862 patients from Eastern Finland. Neuroepidemiology 2011;37:203-208
33. Karamanakos PN, von Und Zu Fraunberg M, Bendel S, et al. Risk factors for three phases of 12-month mortality in 1657 patients from a defined population after acute aneurysmal subarachnoid hemorrhage. World Neurosurg 2012;78:631-639
34. Yasuno K, Bakõrcõoǧlu M, Low SK, et al. Common variant near the endothelin receptor type A (EDNRA) gene is associated with intracranial aneurysm risk. Proc Natl Acad Sci USA 2011;108:19707-19712
35. Fay MP, Feuer EJ. Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med 1997;16:791-801
36. Garwood F. Fiducial limits for the Poisson distribution. Biometrika 1936;28:437-442
37. Adams HP Jr, Putman SF, Kassell NF, Torner JC. Prevalence of diabetes mellitus among patients with subarachnoid hemorrhage. Arch Neurol 1984;41:1033-1035
38. Cornuz J, Sidoti Pinto C, Tevaearai H, Egger M. Risk factors for asymptomatic abdominal aortic aneurysm: systematic review and meta-αnalysis of populationbased screening studies. Eur J Public Health 2004;14:343-349
39. Peltonen M, Korpi-Hyövälti E, Oksa H, et al. Prevalence of obesity, type 2 diabetes, and other disturbances in glucose metabolism in Finland - The FIN-D2D survey. Finnish Medical Journal 2006;3: 163-170 (in Finnish with English summary)